Ausgewählte Publikationen

Steffke C, Baskar K, Bachhuber F, Wiesenfarth M, Dorst J, Schuster J, Schöberl F, Reilich P, Regensburger M, German A, Günther R, Vidovic M, Petri S, Meyer T, Hagenacker T, Grosskreutz J, Weyen U, Weydt P, Haarmeier T, Lingor P, Wolf J, Hermann A, Prudlo J, Günther K, Knehr A, Elmas Z, Parlak Ö, Uzelac Z, Witzel S, Ruf WP, Freischmidt A, Ho R, Weishaupt JH, Ludolph AC, Tumani H, Oeckl P, Brenner D, Catanese A (2025) Targeted proteomics upon treatment with tofersen identifies novel response markers for SOD1-linked amyotrophic lateral sclerosis. Annals of Neurology.

Zanella P, Loss I, Parlato R, Weishaupt JH, Sala C, Verpelli C, Böckers TM, Catanese A (2025) ALS mutations shift the isoelectric point of the KIF5A C-terminal inducing protein aggregation and TDP-43 mislocalization. Journal of Neuroscience.

Lehmann J, Aly A, Steffke C, Fabbio L, Mayer V, Dikwella N, Halablab K, Roselli F, Seiffert S, Boeckers TM, Brenner D, Kabashi E, Mulaw M, Ho R, Catanese A (2024) Heterozygous knockout of Synaptotagmin13 phenocopies ALS features and TP53 activation in human motor neurons. Cell Death & Disease. 

Seidel M, Rajkumar S, Steffke C, Noeth V, Agarwal S, Roger K, Lipecka J, Ludolph A, Guerrera CI, Boeckers T, Catanese A (2023) Propranolol reduces the accumulation of cytotoxic aggregates in C9orf72-ALS/FTD in vitro models. Current Research in Neurobiology.

Aly A, Laszlo ZI, Rajkumar S, Demir T, Hindley N, Lamont DJ, Lehmann J, Seidel M, Sommer D, Franz-Wachtel M, Barletta F, Heumos S, Czemmel S, Kabashi E, Ludolph A, Boeckers TM, Henstridge C, Catanese A (2023) Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS. Acta Neuropathologica.

Catanese A*, Rajkumar S, Sommer D, Masrori P, Hersmus N, Van Damme P, Witzel S, Ludolph A, Ho R, Boeckers TM, Mulaw M* (2023) Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis. Brain. * co-corresponding authors.